Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Byrd

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
Human Molecular Genetics|May 24, 2001
hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decayS A Pitts, H S Kullar, T Stankovic, et al.
Journal of Virology|March 30, 2018
Degradation of a Novel DNA Damage Response Protein, Tankyrase 1 Binding Protein 1, following Adenovirus InfectionNafiseh Chalabi Hagkarim, Ellis L Ryan, Philip J Byrd, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Cross-Platform Assessment of Sub-50 nm Nanopipette Emitters for Native Electrospray Ionization Mass SpectrometryEmily J Byrd, Eileen J Olivares, Zoe J Heidersbach, et al.
Avian Diseases|August 22, 2015
Electron-Beam-Inactivated Vaccine Against Salmonella Enteritidis Colonization in Molting HensPalmy R Jesudhasan, Jackson L McReynolds, Allen J Byrd, et al.
American Journal of Human Genetics|April 16, 1998
ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancerT Stankovic, A M Kidd, A Sutcliffe, et al.
British Journal of Haematology|June 25, 2008
Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patientsBelinda Austen, Giancarlo Barone, Anne Reiman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863A P Venook, C Enders Klein, G Fleming, et al.
Genomics|March 1, 1997
Construction of a transcription map around the gene for ataxia telangiectasia: identification of at least four novel genesT Stankovic, P J Byrd, P R Cooper, et al.
Blood|September 6, 2003
Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responsesTatjana Stankovic, Mike Hubank, Debbie Cronin, et al.
Nature Communications|August 25, 2022
Single residue modulators of amyloid formation in the N-terminal P1-region of α-synucleinSabine M Ulamec, Roberto Maya-Martinez, Emily J Byrd, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Human Molecular Genetics|May 24, 2001
hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decayS A Pitts, H S Kullar, T Stankovic, et al.
Journal of Virology|March 30, 2018
Degradation of a Novel DNA Damage Response Protein, Tankyrase 1 Binding Protein 1, following Adenovirus InfectionNafiseh Chalabi Hagkarim, Ellis L Ryan, Philip J Byrd, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Cross-Platform Assessment of Sub-50 nm Nanopipette Emitters for Native Electrospray Ionization Mass SpectrometryEmily J Byrd, Eileen J Olivares, Zoe J Heidersbach, et al.
Avian Diseases|August 22, 2015
Electron-Beam-Inactivated Vaccine Against Salmonella Enteritidis Colonization in Molting HensPalmy R Jesudhasan, Jackson L McReynolds, Allen J Byrd, et al.
American Journal of Human Genetics|April 16, 1998
ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancerT Stankovic, A M Kidd, A Sutcliffe, et al.
British Journal of Haematology|June 25, 2008
Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patientsBelinda Austen, Giancarlo Barone, Anne Reiman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863A P Venook, C Enders Klein, G Fleming, et al.
Genomics|March 1, 1997
Construction of a transcription map around the gene for ataxia telangiectasia: identification of at least four novel genesT Stankovic, P J Byrd, P R Cooper, et al.
Blood|September 6, 2003
Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responsesTatjana Stankovic, Mike Hubank, Debbie Cronin, et al.
Nature Communications|August 25, 2022
Single residue modulators of amyloid formation in the N-terminal P1-region of α-synucleinSabine M Ulamec, Roberto Maya-Martinez, Emily J Byrd, et al.
Pageof 24